Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Veritas Genetics Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10383
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Veritas Genetics Inc (Veritas Genetics) is a genome sequencing company that offers genomics testing and sequencing products and services. The company delivers actionable genetic insights to individuals and their doctors based on their DNA to manage their disease risk and plan their family health. Its products include myGenome, myBRCA, myBRCA HiRisk, myPrenatal, mycarrier, and myNewborn. Veritas Genetics’ myBRCA HiRisk is a multi-gene test to screen for hereditary breast and ovarian cancer risk. The company works with scientists, physicians, advisors, and patient advocates to design and deliver genetic testing solutions. It also has its presence in Shanghai and Hangzhou, China. Veritas Genetics is headquartered in Danvers, Massachusetts, the US.

Veritas Genetics Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veritas Genetics Inc, Medical Equipment, Deal Details 10
Venture Financing 10
Veritas Genetics Raises USD1.7 Million in Venture Financing 10
Veritas Genetics Raises USD30 Million in Series B Financing 11
Veritas Genetics Raises USD10 Million in Series A Financing Round 12
Equity Offering 13
Veritas Genetics Raises USD9.6 Million in Financing 13
Acquisition 14
Veritas Genetics Acquires Curoverse 14
Veritas Genetics Inc – Key Competitors 15
Veritas Genetics Inc – Key Employees 16
Veritas Genetics Inc – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Recent Developments 18
Strategy And Business Planning 18
Mar 28, 2018: Veritas Genetics Collaborates with Dr. Steven Narod and Women’s College Hospital to Launch The Screen Project – a Population-Based BRCA Screening Initiative across Canada 18
Corporate Communications 19
Jun 15, 2017: Veritas Genetics Welcomes Dr. Robert C. Green and Dr. Natasha Y. Frank to its Medical & Scientific Advisory Board 19
Feb 08, 2017: Globally Renowned Molecular Genetics Expert, Birgit Funke, PhD, Joins Veritas Genetics as Vice President of Clinical Affairs 20
Legal and Regulatory 21
Jun 01, 2018: Veritas Genetics China Passes CAP & CLIA Inspections for Next Generation Sequencing 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Veritas Genetics Inc, Medical Equipment, Key Facts 2
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Deals By Market, 2012 to YTD 2018 8
Veritas Genetics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Veritas Genetics Raises USD1.7 Million in Venture Financing 10
Veritas Genetics Raises USD30 Million in Series B Financing 11
Veritas Genetics Raises USD10 Million in Series A Financing Round 12
Veritas Genetics Raises USD9.6 Million in Financing 13
Veritas Genetics Acquires Curoverse 14
Veritas Genetics Inc, Key Competitors 15
Veritas Genetics Inc, Key Employees 16
Veritas Genetics Inc, Other Locations 17
Veritas Genetics Inc, Subsidiaries 17

List of Figures
Veritas Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Veritas Genetics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Veritas Genetics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Veritas Genetics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Veritas Genetics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Veritas Genetics Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Oshkosh Corporation:企業の戦略・SWOT・財務分析
    Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report Summary Oshkosh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • TetraLogic Pharmaceuticals (TLOG)-製薬・医療分野:企業M&A・提携分析
    Summary TetraLogic Pharmaceuticals (TetraLogic) is a biopharmaceutical company that research and develops novel small molecule therapeutics in the areas of oncology and infectious diseases. The company’s clinical stage products include birinapant and SHAPE. Its birinapant is a small molecule therape …
  • Banco BPM S.p.A.:企業の戦略・SWOT・財務分析
    Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Banco BPM S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Trade Union Cooperative Insurance Company:企業の戦略・SWOT・財務情報
    Trade Union Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Trade Union Cooperative Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • AENZA SAA (AENZAC1):企業の財務・戦略的SWOT分析
    AENZA SAA (AENZAC1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Cosan S.A. Industria e Comercio (CSAN3):電力:M&Aディール及び事業提携情報
    Summary Cosan S.A. Industria e Comercio (Cosan), a subsidiary of Cosan Limited, is an integrated bioenergy company. It invests in diversified industries including agribusiness, fuel and natural gas distribution, and lubricants. The company distributes lubricants, fuel oil, and piped natural gas; and …
  • Helomics Corp-製薬・医療分野:企業M&A・提携分析
    Summary Helomics Corp(Helomics) is a life science company that develops and offers precision medicine support tools and services for cancer treatment. The company’s products include chemofx, biospecifx, genefx colon and genefx lung. Its chemofx is a drug response marker, which is used to test tumor …
  • Guided Therapeutics Inc (GTHP):企業の財務・戦略的SWOT分析
    Summary Guided Therapeutics Inc (GTI), formerly SpectRx Inc is a biotechnology company that offers platform technology for the early detection of disease that leads to cancer. The company provides products for the non-invasive cervical cancer detection markets. Its products include luviva, a non-inv …
  • Evonik Industries Ag
    Evonik Industries Ag - Strategy, SWOT and Corporate Finance Report Summary Evonik Industries Ag - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ClubCorp Holdings Inc:企業のM&A・事業提携・投資動向
    ClubCorp Holdings Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's ClubCorp Holdings Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • Sirius XM Holdings Inc.:企業の戦略・SWOT・財務情報
    Sirius XM Holdings Inc. - Strategy, SWOT and Corporate Finance Report Summary Sirius XM Holdings Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • PGE Polska Grupa Energetyczna SA (PGE):企業の財務・戦略的SWOT分析
    PGE Polska Grupa Energetyczna SA (PGE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Mycenax Biotech Inc (4726):企業の財務・戦略的SWOT分析
    Summary Mycenax Biotech Inc (Mycenax) is a biopharmaceutical company that develops and manufactures pharmaceutical formulations. The company provides pipeline portfolio encompasses investigational candidates targeted at the treatment of plaque psoriasis, glioblastoma, asthma, adult crohn's Disease, …
  • Stentys SA (STNT):医療機器:M&Aディール及び事業提携情報
    Summary Stentys SA (Stentys) is a medical device company that designs, develops and markets self-expanding stents for the treatment of patients with acute myocardial infarction and coronary disease. The company’s products include xposition S self-applying stent, mistent biodegradable sirolimus relea …
  • Astron Corporation Ltd (ATR):企業の財務・戦略的SWOT分析
    Astron Corporation Ltd (ATR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Inception Sciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Inception Sciences Inc (Inception Sciences) is a pharmaceutical company that offers drug discovery incubators. The company develops new companies in partnership with academic researchers and biopharmaceutical companies. It develops drugs for various indications such as fibrotic diseases, onc …
  • XBiotech Inc (XBIT):企業の財務・戦略的SWOT分析
    Summary XBiotech Inc (XBiotech) is a biopharmaceutical company that discovers, develops and commercialize therapeutic antibodies based proprietary technology. The company provides monoclonal antibodies treatment for various diseases. It’s lead product Xilonix, a therapeutic antibody being developed …
  • Clinical Laserthermia Systems AB (CLS B):企業の財務・戦略的SWOT分析
    Clinical Laserthermia Systems AB (CLS B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Safaricom Ltd
    Safaricom Ltd - Strategy, SWOT and Corporate Finance Report Summary Safaricom Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Triple-S Management Corp (GTS):企業の財務・戦略的SWOT分析
    Triple-S Management Corp (GTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆